Phagenesis' Other Investors

Phagenesis raised a round of funding on , . Investors include Ranworth Capital.

Phagenesis has developed a clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient's ability to swallow is damaged. Dysphagia can lead to the inhalati…

Articles about Phagenesis' Other Investors: